Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Overweight (Without Type 2 Diabetes) With Weight-related Comorbidities”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Not applicableLooking for participantsNCT07780188
What this trial is testing

Lean Beef as Part of a Healthy Meal Plan in Adolescents With Polycystic Ovary Syndrome (PCOS)/Polyendocrine Metabolic Ovarian Syndrome (PMOS)

Who this might be right for
PCOS (Polycystic Ovary Syndrome)Obese AdolescentsOverweight (Without Type 2 Diabetes) With Weight-related Comorbidities+5 more
Texas A&M University 36
Large-scale testing (Phase 3)Looking for participantsNCT07279194
What this trial is testing

Efficacy and Safety of HDM1005 in Chinese Obesity or Overweight Patients Without Diabetes

Who this might be right for
Obesity & Overweight
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 825
Large-scale testing (Phase 3)Active Not RecruitingNCT06972459
What this trial is testing

Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity

Who this might be right for
ObesityOverweight
Eli Lilly and Company 800
Large-scale testing (Phase 3)Study completedNCT04184622
What this trial is testing

Tirzepatide (LY3298176) in Participants With Obesity or Overweight

Who this might be right for
OverweightObesity
Eli Lilly and Company 2,539
Large-scale testing (Phase 3)Study completedNCT05024032
What this trial is testing

Tirzepatide (LY3298176) in Chinese Participants Without Type 2 Diabetes Who Have Obesity or Overweight (SURMOUNT-CN)

Who this might be right for
ObesityOverweightMetabolism and Nutrition Disorder
Eli Lilly and Company 210
Large-scale testing (Phase 3)Study completedNCT04657016
What this trial is testing

Tirzepatide (LY3298176) In Participants After A Lifestyle Weight Loss Program

Who this might be right for
ObesityOverweight
Eli Lilly and Company 579
Not applicableEnrolling By InvitationNCT07736547
What this trial is testing

AIM-WEIGHT: AI-Guided Microbiome-Targeted Nutritional Intervention for Weight Loss

Who this might be right for
Overweight (Without Type 2 Diabetes) With Weight-related ComorbiditiesOverweight (BMI > 25)
Varol TUNALI 80
Large-scale testing (Phase 3)Looking for participantsNCT07776509
What this trial is testing

Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

Who this might be right for
Obesity or OverweightWeight-Related ComorbidityWith/Without Diabetes Mellitus, Type 2
AstraZeneca 500
Large-scale testing (Phase 3)Looking for participantsNCT07481747
What this trial is testing

Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo in Participants Who Are Either Obese or Overweight With Weight-Related Comorbidities (SURMOUNT-1)

Who this might be right for
ObesityOverweight (Without Type 2 Diabetes) With Weight-related Comorbidities
Hudson Biotech 2,539
Not applicableNot Yet RecruitingNCT07609160
What this trial is testing

Effectiveness of Combined GLP-1/GIP Dual Agonist Therapy and Structured Exercise on Skeletal Muscle Morphology, Quality, and Physical Function in Overweight and Obese Individuals

Who this might be right for
ObesitySarcopeniaOverweight (Without Type 2 Diabetes) With Weight-related Comorbidities
Acibadem University 108
Large-scale testing (Phase 3)Looking for participantsNCT07784725
What this trial is testing

Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Who this might be right for
Obesity or Overweight
AstraZeneca 2,500
Large-scale testing (Phase 3)Study completedNCT04660643
What this trial is testing

Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight Loss

Who this might be right for
ObesityOverweight
Eli Lilly and Company 783